Increase in pediatric recurrent fever evaluations during the first year of the COVID-19 pandemic in North America
© 2023 Mansfield, Lapidus, Romero, Moorthy, Adler-Shohet, Hollander, Cherian, Twilt, Lionetti, Mohan, DeLaMora, Durrant, Muskardin, Correia Marques, Onel, Dedeoglu, Gutierrez, Schulert and the CARRA Autoinflammatory Network Consortium for the CARRA PFAPA/Autoinflamamtory Working Group..
The impact of the COVID-19 pandemic on new diagnoses of recurrent fevers and autoinflammatory diseases is largely unknown. The Childhood Arthritis and Rheumatology Research Alliance (CARRA) PFAPA/AID Working Group aimed to investigate the impact of the COVID-19 pandemic on the number of pediatric patients evaluated for recurrent fevers and autoinflammatory diseases in North America. The absolute number of new outpatient visits and the proportion of these visits attributed to recurrent fever diagnoses during the pre-pandemic period (1 March 2019-29 February 2020) and the first year of the COVID-19 pandemic (1 March 2020-28 February 2021) were examined. Data were collected from 27 sites in the United States and Canada. Our results showed an increase in the absolute number of new visits for recurrent fever evaluations in 21 of 27 sites during the COVID-19 pandemic compared to the pre-pandemic period. The increase was observed across different geographic regions in North America. Additionally, the proportion of new visits to these centers for recurrent fever in relation to all new patient evaluations was significantly higher during the first year of the pandemic, increasing from 7.8% before the pandemic to 10.9% during the pandemic year (p < 0.001). Our findings showed that the first year of the COVID-19 pandemic was associated with a higher number of evaluations by pediatric subspecialists for recurrent fevers. Further research is needed to understand the reasons behind these findings and to explore non-infectious triggers for recurrent fevers in children.
| Errataetall: |
ErratumIn: Front Pediatr. 2023 Nov 06;11:1323946. - PMID 38027299 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
|---|---|
| Enthalten in: |
Frontiers in pediatrics - 11(2023) vom: 06., Seite 1240242 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
CARRA |
|---|
| Anmerkungen: |
Date Revised 13.12.2023 published: Electronic-eCollection ErratumIn: Front Pediatr. 2023 Nov 06;11:1323946. - PMID 38027299 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.3389/fped.2023.1240242 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM360998291 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM360998291 | ||
| 003 | DE-627 | ||
| 005 | 20231227131503.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3389/fped.2023.1240242 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1225.xml |
| 035 | |a (DE-627)NLM360998291 | ||
| 035 | |a (NLM)37601132 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Mansfield, Leanne M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Increase in pediatric recurrent fever evaluations during the first year of the COVID-19 pandemic in North America |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 13.12.2023 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a ErratumIn: Front Pediatr. 2023 Nov 06;11:1323946. - PMID 38027299 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2023 Mansfield, Lapidus, Romero, Moorthy, Adler-Shohet, Hollander, Cherian, Twilt, Lionetti, Mohan, DeLaMora, Durrant, Muskardin, Correia Marques, Onel, Dedeoglu, Gutierrez, Schulert and the CARRA Autoinflammatory Network Consortium for the CARRA PFAPA/Autoinflamamtory Working Group. | ||
| 520 | |a The impact of the COVID-19 pandemic on new diagnoses of recurrent fevers and autoinflammatory diseases is largely unknown. The Childhood Arthritis and Rheumatology Research Alliance (CARRA) PFAPA/AID Working Group aimed to investigate the impact of the COVID-19 pandemic on the number of pediatric patients evaluated for recurrent fevers and autoinflammatory diseases in North America. The absolute number of new outpatient visits and the proportion of these visits attributed to recurrent fever diagnoses during the pre-pandemic period (1 March 2019-29 February 2020) and the first year of the COVID-19 pandemic (1 March 2020-28 February 2021) were examined. Data were collected from 27 sites in the United States and Canada. Our results showed an increase in the absolute number of new visits for recurrent fever evaluations in 21 of 27 sites during the COVID-19 pandemic compared to the pre-pandemic period. The increase was observed across different geographic regions in North America. Additionally, the proportion of new visits to these centers for recurrent fever in relation to all new patient evaluations was significantly higher during the first year of the pandemic, increasing from 7.8% before the pandemic to 10.9% during the pandemic year (p < 0.001). Our findings showed that the first year of the COVID-19 pandemic was associated with a higher number of evaluations by pediatric subspecialists for recurrent fevers. Further research is needed to understand the reasons behind these findings and to explore non-infectious triggers for recurrent fevers in children | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a CARRA | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a fevers | |
| 650 | 4 | |a pediatric | |
| 650 | 4 | |a recurrent | |
| 650 | 4 | |a rheumatology | |
| 700 | 1 | |a Lapidus, Sivia K |e verfasserin |4 aut | |
| 700 | 1 | |a Romero, Samira Nazzar |e verfasserin |4 aut | |
| 700 | 1 | |a Moorthy, Lakshmi N |e verfasserin |4 aut | |
| 700 | 1 | |a Adler-Shohet, Felice C |e verfasserin |4 aut | |
| 700 | 1 | |a Hollander, Matthew |e verfasserin |4 aut | |
| 700 | 1 | |a Cherian, Julie |e verfasserin |4 aut | |
| 700 | 1 | |a Twilt, Marinka |e verfasserin |4 aut | |
| 700 | 1 | |a Lionetti, Geraldina |e verfasserin |4 aut | |
| 700 | 1 | |a Mohan, Smriti |e verfasserin |4 aut | |
| 700 | 1 | |a DeLaMora, Patricia A |e verfasserin |4 aut | |
| 700 | 1 | |a Durrant, Karen L |e verfasserin |4 aut | |
| 700 | 1 | |a Muskardin, Theresa Wampler |e verfasserin |4 aut | |
| 700 | 1 | |a Correia Marques, Mariana |e verfasserin |4 aut | |
| 700 | 1 | |a Onel, Karen B |e verfasserin |4 aut | |
| 700 | 1 | |a Dedeoglu, Fatma |e verfasserin |4 aut | |
| 700 | 1 | |a Gutierrez, Maria J |e verfasserin |4 aut | |
| 700 | 1 | |a Schulert, Grant |e verfasserin |4 aut | |
| 700 | 0 | |a CARRA Autoinflammatory Network Consortium for the CARRA PFAPA/Autoinflammatory Working Group |e verfasserin |4 aut | |
| 700 | 1 | |a Akoghlanian, Shoghik |e investigator |4 oth | |
| 700 | 1 | |a Aguiar, Cassyanne L |e investigator |4 oth | |
| 700 | 1 | |a Basiaga, Matthew |e investigator |4 oth | |
| 700 | 1 | |a Hui-Yuen, Joyce |e investigator |4 oth | |
| 700 | 1 | |a Kessler, Elizabeth A |e investigator |4 oth | |
| 700 | 1 | |a Lai, Jamie |e investigator |4 oth | |
| 700 | 1 | |a Nolan, Brian E |e investigator |4 oth | |
| 700 | 1 | |a Nolan, Sheila |e investigator |4 oth | |
| 700 | 1 | |a Oliver, Melissa S |e investigator |4 oth | |
| 700 | 1 | |a Tory, Heather O |e investigator |4 oth | |
| 700 | 1 | |a Panupattanapong, Sirada |e investigator |4 oth | |
| 700 | 1 | |a Piram, Maryam |e investigator |4 oth | |
| 700 | 1 | |a Szymanski, Ann |e investigator |4 oth | |
| 700 | 1 | |a Vogel, Tiphanie |e investigator |4 oth | |
| 700 | 1 | |a Wu, Eveline |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Frontiers in pediatrics |d 2013 |g 11(2023) vom: 06., Seite 1240242 |w (DE-627)NLM234254327 |x 2296-2360 |7 nnns |
| 773 | 1 | 8 | |g volume:11 |g year:2023 |g day:06 |g pages:1240242 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3389/fped.2023.1240242 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 11 |j 2023 |b 06 |h 1240242 | ||